Neurological Disorders Therapies
Articles & Whitepapers
-
CanaQuest President Interviewed by the Wall Street Analyzer
The attached is the transcript of an interview conducted by the Wall Street Analyzer with Paul Ramsay, President of CanaQuest Medical Corp. and posted on the Wall Street Analyzer’s website on January 5, 2023. Additionally, the full interview can be listened to on the Wall Street Analyzer’s website - Canaquest Medical Corp (OTC: CANQF) | The Wall Street Analyzer Interview Notes: 1. ...
-
EpiFinder Takes a 5,504-Mile Road Trip to Share Its Mission
In late November, EpiFinder Co-Founder Neel Mehta and Creative Officer Kristi Kietzmann left Arizona for a cross-country road trip. The journey from Arizona to Washington D.C. covered 5,504 miles ...
News
-
Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders
On March 15th 2015, Tim Buckinx’ son said: “Papa, you work in digital, can’t you create a light that turns on when my brain switches off?” At ten years old, he was simply fed up with the daily impact of his refractory ...
Empatica partnering with U.S. Army MRDC to deploy COVID-19 early detection wearable
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
CANAQUEST Announces Award of European Cannabinoid Patent
Equipment & Solutions
-
Showcase
Seizure Alarm
The seizure alarm is developed to register and alert in case of a tonic-clonic seizure. The electronics incorporated in the sensor identifies a seizure by recognising the distinctive movements. Epi-Care 3000 does not react to normal movements during sleep. he level of sensitivity and the alarm timer of Epi-Care 3000 can be adjusted according to the user’s pattern of seizures and the ...